Product
Nimotop
Aliases
Nimotop 30 MG Oral Capsule
2 clinical trials
5 indications
Indication
EpilepsyIndication
Major Depressive DisorderIndication
Postictal deliriumIndication
Electroconvulsive therapyClinical trial
Safety and Tolerability of GTX-104 (Nimodipine Injection for IV Infusion) Compared With Oral Nimodipine in Patients Hospitalized for Aneurysmal Subarachnoid Hemorrhage (aSAH): a Prospective, Randomized TrialStatus: Recruiting, Estimated PCD: 2024-11-01
Clinical trial
StudY of Effect of Nimodipine and Acetaminophen on Postictal Symptoms After ECTStatus: Completed, Estimated PCD: 2022-12-30